Keyphrases
Novel Therapeutics
100%
Meta-analysis
100%
Primary Prevention
100%
Implantable Defibrillator
100%
Nonischemic Cardiomyopathy
100%
Angiotensin Receptor-neprilysin Inhibitor
44%
Mortality Benefit
33%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
22%
Cardioverter-defibrillator Implantation
22%
Sodium-glucose Transport Protein 2 Inhibitors
22%
Randomized Controlled Trial
11%
Regression Analysis
11%
Decreased Risk
11%
Improved Outcomes
11%
Heart Failure
11%
PubMed
11%
Meta-regression
11%
Literature Search
11%
Current Guidelines
11%
Amiodarone
11%
Dapagliflozin
11%
Left Bundle Branch Block
11%
Angiotensin Receptor Blockers
11%
Prospero
11%
Sudden Cardiac Death Prevention
11%
Metanalysis
11%
Novel Medications
11%
Optimal Medical Treatment
11%
Clinical Outcomes
11%
Angiotensin-converting Enzyme Inhibitor (ACEi)
11%
Mortality Effect
11%
Medicine and Dentistry
Meta-Analysis
100%
Therapeutic Agent
100%
Primary Prevention
100%
Implantable Automatic Defibrillator
100%
Nonischemic Cardiomyopathy
100%
Dilated Cardiomyopathy
54%
Enkephalinase Inhibitor
36%
Angiotensin Receptor
36%
Sodium Glucose Cotransporter 2 Inhibitor
18%
Meta-Regression
18%
Sodium Glucose Cotransporter
18%
Combination Therapy
9%
Drug Therapy
9%
Cohort Analysis
9%
Heart Failure
9%
ACE Inhibitor
9%
Amiodarone
9%
Randomized Controlled Trial
9%
Left Bundle Branch Block
9%
Angiotensin Receptor Antagonist
9%
Dapagliflozin
9%
Sudden Cardiac Death
9%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Cardiomyopathy
100%
Nonischemic Cardiomyopathy
100%
Enkephalinase Inhibitor
66%
Angiotensin Receptor
66%
Sodium Glucose Cotransporter 2 Inhibitor
33%
Sodium Glucose Cotransporter
33%
Cohort Study
16%
Randomized Controlled Trial
16%
Heart Failure
16%
Amiodarone
16%
Dipeptidyl Carboxypeptidase Inhibitor
16%
Angiotensin Receptor Antagonist
16%
Heart Left Bundle Branch Block
16%
Combination Therapy
16%
Dapagliflozin
16%
Sudden Cardiac Death
16%
Neuroscience
Meta-Analysis
100%
Cardiomyopathy
100%
Dilated Cardiomyopathy
100%
Angiotensin Receptor
83%
Enkephalinase Inhibitor
66%
Sodium Glucose Cotransporter
33%
Amiodarone
16%
Dapagliflozin
16%
ACE Inhibitor
16%
Left Bundle Branch Block
16%